AKT1 and hereditary disease: This study provides new mechanistic insights on how Hcy exerted neurotoxicity and enhances pathogenesis of stroke, implicating the PI3K-AKT- and ERK- dependent mTOR pathway as potential therapeutic targets for the stroke patient especially due to genetic disorders of Hcy metabolism.